Skip to main content

Chronic Disease

2
Pipeline Programs
17
Companies
21
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

17 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
3 programs
1
1
morphine sulfate and naltrexone hydrochloridePhase 41 trial
GH treatmentPhase 31 trial
Hospital-Based Vaccination PathwayN/A1 trial
Active Trials
NCT07391046Not Yet Recruiting1,500Est. Feb 2027
NCT00813189Completed30Est. May 2012
NCT01179191Terminated684Est. Apr 2011
Innovation Pharmaceuticals
3 programs
DigiKnowIt NewsN/A1 trial
Enhanced Integrated Behavioral Health CareN/A1 trial
TeNDER toolN/A1 trial
Active Trials
NCT03531866Completed91Est. Aug 2018
NCT03916016Completed585Est. Mar 2018
NCT05681065Completed534Est. Apr 2023
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
2 programs
MY-Skills MobileN/A1 trial
Transportation and Developmental ScreeningN/A
Active Trials
NCT04758312Completed30Est. Jun 2022
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
2 programs
Nutrition Management and Dietary FiberN/A1 trial
Patient Self-Directed CareN/A
Active Trials
NCT04690075Unknown120Est. Jun 2021
Medtronic
MedtronicNJ - Phillipsburg
1 program
Adjunct TherapyN/A1 trial
Active Trials
NCT02659280Completed47Est. Nov 2017
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Biospecimen CollectionN/A1 trial
Active Trials
NCT04160429RecruitingEst. Jul 2029
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Complex care management programN/A1 trial
Active Trials
NCT06916247Recruiting5,000Est. May 2026
Concerto Biosciences
Concerto BiosciencesMA - Cambridge
1 program
Concerto+N/A1 trial
Active Trials
NCT03628963Unknown200Est. Nov 2019
Francis Medical
Francis MedicalMN - Maple Grove
1 program
Conversation card gameN/A1 trial
Active Trials
NCT02619370Completed34Est. Sep 2016
Shield Therapeutics
Shield TherapeuticsMA - Wellesley
1 program
Enhanced SupportN/A1 trial
Active Trials
NCT00793260Completed174,120Est. May 2008
Nordic Pharma
Nordic PharmaFrance - Paris
1 program
Health-related Quality of Life in Patients at Nordic ClinicN/A1 trial
Active Trials
NCT04611074Terminated21Est. Mar 2023
Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
1 program
Invitation to adoptN/A1 trial
Active Trials
NCT06073041Completed20Est. Nov 2024
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Medicaid ExpansionN/A1 trial
Active Trials
NCT02657499Completed1,939,848Est. Oct 2018
Alliance Pharmaceuticals
1 program
Patient Self-Directed CareN/A1 trial
Active Trials
NCT02318797Completed1,229Est. Jan 2017
Verona Pharma
Verona PharmaUK - London
1 program
Proactive InterventionN/A1 trial
Active Trials
NCT07479810Enrolling By Invitation100Est. Sep 2026
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Sub-study for the Validation and Calibration of Data Regarding Physical Activity, Anthropometry and N/A1 trial
Active Trials
NCT03216161Completed816Est. Dec 2012
Medpace
MedpaceCINCINNATI, OH
1 program
Transportation and Developmental ScreeningN/A1 trial
Active Trials
NCT06160037Completed1,055Est. May 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Pfizermorphine sulfate and naltrexone hydrochloride
PfizerGH treatment
PfizerHospital-Based Vaccination Pathway
Verona PharmaProactive Intervention
Angeles TherapeuticsComplex care management program
Temple TherapeuticsInvitation to adopt
Innovation PharmaceuticalsTeNDER tool
Colorado TherapeuticsMY-Skills Mobile
UNION therapeuticsNutrition Management and Dietary Fiber
MedpaceTransportation and Developmental Screening
Nordic PharmaHealth-related Quality of Life in Patients at Nordic Clinic
City TherapeuticsBiospecimen Collection
Concerto BiosciencesConcerto+
Innovation PharmaceuticalsDigiKnowIt News
MedtronicAdjunct Therapy

Showing 15 of 21 trials with date data

Clinical Trials (21)

Total enrollment: 2,126,064 patients across 21 trials

NCT01179191Pfizermorphine sulfate and naltrexone hydrochloride

Conversion to Embeda With Rescue Trial

Start: Aug 2010Est. completion: Apr 2011684 patients
Phase 4Terminated
NCT00813189PfizerGH treatment

Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid

Start: Apr 2005Est. completion: May 201230 patients
Phase 3Completed
NCT07391046PfizerHospital-Based Vaccination Pathway

Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients

Start: Feb 2026Est. completion: Feb 20271,500 patients
N/ANot Yet Recruiting
NCT07479810Verona PharmaProactive Intervention

Chronic Diseases in Primary Care

Start: Nov 2024Est. completion: Sep 2026100 patients
N/AEnrolling By Invitation
NCT06916247Angeles TherapeuticsComplex care management program

Evaluation of AI Cost Prediction Model to Enroll Patients in Complex Care Management Program

Start: Aug 2024Est. completion: May 20265,000 patients
N/ARecruiting
NCT06073041Temple TherapeuticsInvitation to adopt

Implementing and Evaluating the Integration of Physical Activity Into a Major Health System and Connecting Patients to Physical Activity Programs.

Start: Aug 2023Est. completion: Nov 202420 patients
N/ACompleted
NCT05681065Innovation PharmaceuticalsTeNDER tool

Affective Based Integrated Care for Better Quality of Life.Pilot Implementation. Site1: Primary Care Madrid, Spain.

Start: Apr 2021Est. completion: Apr 2023534 patients
N/ACompleted
NCT04758312Colorado TherapeuticsMY-Skills Mobile

A Mobile Intervention Merging Yoga and Self-Management Skills

Start: Mar 2021Est. completion: Jun 202230 patients
N/ACompleted
NCT04690075UNION therapeuticsNutrition Management and Dietary Fiber

Effect of Dietary Fiber on Metabolism, Inflammation and Nutritional Status in Patients With Chronic Diseases

Start: Dec 2020Est. completion: Jun 2021120 patients
N/AUnknown
NCT06160037MedpaceTransportation and Developmental Screening

Influence of Prenatal and Early Childhood Home-Visiting by Nurses on Development of Chronic Disease

Start: May 2020Est. completion: May 20241,055 patients
N/ACompleted
NCT04611074Nordic PharmaHealth-related Quality of Life in Patients at Nordic Clinic

Health-related Quality of Life in Patients at Nordic Clinic

Start: Aug 2019Est. completion: Mar 202321 patients
N/ATerminated
NCT04160429City TherapeuticsBiospecimen Collection

Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving Meditations

Start: Nov 2018Est. completion: Jul 2029
N/ARecruiting
NCT03628963Concerto BiosciencesConcerto+

Optimizing Patient Usability Experience for Chronic Care

Start: Sep 2018Est. completion: Nov 2019200 patients
N/AUnknown
NCT03531866Innovation PharmaceuticalsDigiKnowIt News

Evaluation Study of Web-based Resource for Youth

Start: May 2018Est. completion: Aug 201891 patients
N/ACompleted
NCT02659280MedtronicAdjunct Therapy

Using "Store and Forward" Tele-health as an Adjunct to Traditional Outpatient or Home Health Physical Therapy

Start: Mar 2016Est. completion: Nov 201747 patients
N/ACompleted
NCT02619370Francis MedicalConversation card game

Evaluation of an Advance Care Planning Activity: Feasibility Testing for a Randomized Controlled Trial

Start: Jan 2016Est. completion: Sep 201634 patients
N/ACompleted
NCT03916016Innovation PharmaceuticalsEnhanced Integrated Behavioral Health Care

Sí Texas Hope Family Health Center

Start: Dec 2015Est. completion: Mar 2018585 patients
N/ACompleted
NCT02318797Alliance PharmaceuticalsPatient Self-Directed Care

Optimizing Behavioral Health Homes for Adults With Serious Mental Illness

Start: Oct 2013Est. completion: Jan 20171,229 patients
N/ACompleted
NCT02657499Oregon TherapeuticsMedicaid Expansion

Post Affordable Care Act Evaluation

Start: Jan 2012Est. completion: Oct 20181,939,848 patients
N/ACompleted
NCT03216161Human BioSciencesSub-study for the Validation and Calibration of Data Regarding Physical Activity, Anthropometry and

Sub-study for the Validation and Calibration of Data Regarding Physical Activity, Anthropometry and Diet

Start: Aug 2010Est. completion: Dec 2012816 patients
N/ACompleted
NCT00793260Shield TherapeuticsEnhanced Support

Deep Dive Randomized Control Trial

Start: Jul 2006Est. completion: May 2008174,120 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
2 actively recruiting trials targeting 2,126,064 patients
17 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.